Prostate Cancer

Latest News

FDA greenlights phase 3 study of LAE201 in mCRPC
FDA greenlights phase 3 study of LAE201 in mCRPC

May 23rd 2024

"Since the phase 2 data of the combination therapy of LAE002 (afuresertib) plus LAE001 demonstrated encouraging anti-tumor activity and safety profile in patients with mCRPC, a following phase 3 pivotal trial design has been discussed with the US FDA and the approval for the protocol has been received this month," said Yong Yue, MD, PhD.

New tool reveals impact of prostate cancer on sexual health of female partners
New tool reveals impact of prostate cancer on sexual health of female partners

May 22nd 2024

Study establishes proof of concept for TLX592 in prostate cancer
Study establishes proof of concept for TLX592 in prostate cancer

May 21st 2024

Galen Prostate shows potential to enhance prostate cancer detection
Galen Prostate shows potential to enhance prostate cancer detection

May 20th 2024

Cell-cycle risk score is predictive of ADT benefit in prostate cancer
Cell-cycle risk score is predictive of ADT benefit in prostate cancer

May 17th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.